Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Xiaoxia Jia in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Yaxin An in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Yuechao Xu in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Yuxian Yang in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Chang Liu in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Dong Zhao in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Jing Ke in
Google Scholar
PubMed
Introduction Osteoporosis and related fractures commonly exist in patients with type 2 diabetes mellitus (T2DM), which results in a great economic and social burden in the aging society ( 1 ). It has been reported that diabetes mellitus was an
Search for other papers by Kathrin R Frey in
Google Scholar
PubMed
Search for other papers by Tina Kienitz in
Google Scholar
PubMed
Search for other papers by Julia Schulz in
Google Scholar
PubMed
Search for other papers by Manfred Ventz in
Google Scholar
PubMed
Search for other papers by Kathrin Zopf in
Google Scholar
PubMed
Search for other papers by Marcus Quinkler in
Google Scholar
PubMed
-induced decline in bone formation is associated with an increased fracture risk related both to the dose and duration of GC treatment ( 2 ). Recent studies on bone mineral density (BMD) in PAI and CAH patients showed different results. This may be not only due to
Search for other papers by M Ahmid in
Google Scholar
PubMed
Search for other papers by C G Perry in
Google Scholar
PubMed
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Search for other papers by M G Shaikh in
Google Scholar
PubMed
studies. Figure 2 Flow diagram of the literature review process and selection of studies. Consequences of rhGH cessation and replacement during transition Bone mass and risk of fracture Bone mass Cross-sectional and
Search for other papers by Keina Nishio in
Google Scholar
PubMed
Search for other papers by Akiko Tanabe in
Google Scholar
PubMed
Search for other papers by Risa Maruoka in
Google Scholar
PubMed
Search for other papers by Kiyoko Nakamura in
Google Scholar
PubMed
Search for other papers by Masaaki Takai in
Google Scholar
PubMed
Search for other papers by Tatsuharu Sekijima in
Google Scholar
PubMed
Search for other papers by Satoshi Tunetoh in
Google Scholar
PubMed
Search for other papers by Yoshito Terai in
Google Scholar
PubMed
Search for other papers by Masahide Ohmichi in
Google Scholar
PubMed
tomography was significantly higher in comparison to natural menopause women. In addition, risk of osteoporotic fracture may be increased in women who undergo bilateral oophorectomy after natural menopause in comparison to women with intact ovaries (6, 7
Search for other papers by Julia Herteux in
Google Scholar
PubMed
Search for other papers by Simon Johannes Geiger in
Google Scholar
PubMed
Search for other papers by Christina Starchl in
Google Scholar
PubMed
Search for other papers by Johanna Windisch in
Google Scholar
PubMed
Search for other papers by Theresa Lerchl in
Google Scholar
PubMed
Search for other papers by Adelina Tmava-Berisha in
Google Scholar
PubMed
Search for other papers by Gerit Wünsch in
Google Scholar
PubMed
Search for other papers by Kathrin Eller in
Google Scholar
PubMed
Search for other papers by Astrid Fahrleitner-Pammer in
Google Scholar
PubMed
Search for other papers by Karin Amrein in
Google Scholar
PubMed
( 8 , 9 , 10 ). In 2014, the Canadian National Hypoparathyroidism Registry started collecting medical data, including fracture risk, mortality and comorbidities ( 11 ). In a retrospective study design, they were able to evaluate the medical history
Department of Endocrinology, Fujian Provincial Hospital, Fujian, China
Search for other papers by Yaqian Mao in
Google Scholar
PubMed
Search for other papers by Lizhen Xu in
Google Scholar
PubMed
Search for other papers by Ting Xue in
Google Scholar
PubMed
Search for other papers by Jixing Liang in
Google Scholar
PubMed
Search for other papers by Wei Lin in
Google Scholar
PubMed
Search for other papers by Junping Wen in
Google Scholar
PubMed
Search for other papers by Huibin Huang in
Google Scholar
PubMed
Search for other papers by Liantao Li in
Google Scholar
PubMed
Department of Endocrinology, Fujian Provincial Hospital, Fujian, China
Fujian Provincial Key Laboratory of Medical Analysis, Fujian Academy of Medical, Fujian, China
Search for other papers by Gang Chen in
Google Scholar
PubMed
States, OP affects approximately 10 million people, including 2 million men ( 2 ). It is estimated that one in five white men will suffer from osteoporosis-related fractures in their lifetimes ( 3 ). In China, the overall prevalence rate of OP in people
Search for other papers by Jiaxin Zhang in
Google Scholar
PubMed
Search for other papers by Jinlan Jiang in
Google Scholar
PubMed
Search for other papers by Yao Qin in
Google Scholar
PubMed
Search for other papers by Yihui Zhang in
Google Scholar
PubMed
Search for other papers by Yungang Wu in
Google Scholar
PubMed
Search for other papers by Huadong Xu in
Google Scholar
PubMed
measure BMD and define osteoporosis as being ≤2.5 standard deviations ( s.d. ) of the mean BMD in young healthy females ( 1 ). Osteoporosis can cause increased bone fragility and risks of osteoporotic fractures ( 2 ). It was estimated that the annual case
Search for other papers by Anna Eremkina in
Google Scholar
PubMed
Search for other papers by Julia Krupinova in
Google Scholar
PubMed
Search for other papers by Ekaterina Dobreva in
Google Scholar
PubMed
Search for other papers by Anna Gorbacheva in
Google Scholar
PubMed
Search for other papers by Ekaterina Bibik in
Google Scholar
PubMed
Search for other papers by Margarita Samsonova in
Google Scholar
PubMed
Search for other papers by Alina Ajnetdinova in
Google Scholar
PubMed
Search for other papers by Natalya Mokrysheva in
Google Scholar
PubMed
, non-vertebral and hip fractures and increases bone mineral density ( 8 ). At the same time, administering denosumab to patients with advanced cancers and bone metastases significantly decreases the incidence of skeletal-related events and hypercalcemia
Search for other papers by Yi Chen in
Google Scholar
PubMed
Search for other papers by Wen Zhang in
Google Scholar
PubMed
Search for other papers by Chi Chen in
Google Scholar
PubMed
Search for other papers by Yuying Wang in
Google Scholar
PubMed
Search for other papers by Ningjian Wang in
Google Scholar
PubMed
Search for other papers by Yingli Lu in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) is associated with an increased fracture risk ( 1 , 2 , 3 ), which has aroused great concern. One of the most commonly used indicators to assess fracture risk is the bone mineral density (BMD
Search for other papers by Karoline Winckler in
Google Scholar
PubMed
Department of Cardiology, Department of Research, Institute of Clinical Studies, Clinical Research Unit, Department of Paediatrics, Department of Medicine, Department of Physiology and Nuclear Medicine, Institute of Clinical Medicine, Nephrology and Endocrinology
Department of Cardiology, Department of Research, Institute of Clinical Studies, Clinical Research Unit, Department of Paediatrics, Department of Medicine, Department of Physiology and Nuclear Medicine, Institute of Clinical Medicine, Nephrology and Endocrinology
Search for other papers by Lise Tarnow in
Google Scholar
PubMed
Department of Cardiology, Department of Research, Institute of Clinical Studies, Clinical Research Unit, Department of Paediatrics, Department of Medicine, Department of Physiology and Nuclear Medicine, Institute of Clinical Medicine, Nephrology and Endocrinology
Search for other papers by Louise Lundby-Christensen in
Google Scholar
PubMed
Department of Cardiology, Department of Research, Institute of Clinical Studies, Clinical Research Unit, Department of Paediatrics, Department of Medicine, Department of Physiology and Nuclear Medicine, Institute of Clinical Medicine, Nephrology and Endocrinology
Search for other papers by Thomas P Almdal in
Google Scholar
PubMed
Search for other papers by Niels Wiinberg in
Google Scholar
PubMed
Department of Cardiology, Department of Research, Institute of Clinical Studies, Clinical Research Unit, Department of Paediatrics, Department of Medicine, Department of Physiology and Nuclear Medicine, Institute of Clinical Medicine, Nephrology and Endocrinology
Search for other papers by Pia Eiken in
Google Scholar
PubMed
Search for other papers by Trine W Boesgaard in
Google Scholar
PubMed
Search for other papers by the CIMT trial group in
Google Scholar
PubMed
to improved endothelial function, inhibition of foam cell formation and suppression of macrophage cholesterol uptake in patients with T2D (19, 20) . Vitamin D's effect on bone health (fractures and bone mineral density (BMD)) is well established in